Progestin [EPC]

Progestin [EPC] was reported 291345 times

These side effects are most commonly reported by patients taking drugs of the Progestin [EPC] class:

# Drug class Count
0 DEVICE EXPULSION 49529
1 DEVICE DISLOCATION 23664
2 VAGINAL HAEMORRHAGE 19234
3 MENSTRUATION IRREGULAR 17874
4 NO ADVERSE EVENT 14702
5 NAUSEA 11516
6 GENITAL HAEMORRHAGE 11268
7 COMPLICATION OF DEVICE INSERTION 10567
8 HEADACHE 10111
9 ABDOMINAL PAIN 9987
10 DEVICE BREAKAGE 9756
11 ABDOMINAL PAIN LOWER 9639
12 PAIN 9479
13 DEVICE DIFFICULT TO USE 8876
14 PROCEDURAL PAIN 8675
15 DRUG INEFFECTIVE 8468
16 PRODUCT QUALITY ISSUE 7959
17 AMENORRHOEA 7663
18 MENORRHAGIA 7587
19 UTERINE PERFORATION 7467
20 PELVIC PAIN 7208
21 COMPLICATION OF DEVICE REMOVAL 7071
22 COMPLICATION ASSOCIATED WITH DEVICE 7061
23 FATIGUE 7045
24 MENSTRUATION DELAYED 7007
25 DEPRESSION 6906
26 WEIGHT INCREASED 6750
27 ANXIETY 6686
28 PREGNANCY WITH CONTRACEPTIVE DEVICE 6550
29 DYSMENORRHOEA 6085
30 DIZZINESS 6021
31 VOMITING 5958
32 INTRA-UTERINE CONTRACEPTIVE DEVICE EXPELLED 5578
33 DEVICE ISSUE 5426
34 INCORRECT PRODUCT ADMINISTRATION DURATION 5302
35 BACK PAIN 5066
36 METRORRHAGIA 4994
37 INJURY 4835
38 UNINTENDED PREGNANCY 4772
39 DEVICE DEPLOYMENT ISSUE 4720
40 PULMONARY EMBOLISM 4492
41 VAGINAL DISCHARGE 3947
42 EMBEDDED DEVICE 3926
43 MIGRAINE 3648
44 PREGNANCY WITH IMPLANT CONTRACEPTIVE 3529
45 MUSCLE SPASMS 3490
46 ABDOMINAL DISTENSION 3442
47 ALOPECIA 3354
48 PAIN IN EXTREMITY 3281
49 IMPLANT SITE PAIN 3258
50 OFF LABEL USE 3185
51 EMOTIONAL DISTRESS 3079
52 DEEP VEIN THROMBOSIS 3010
53 MOOD SWINGS 2977
54 ACNE 2913
55 HEAVY MENSTRUAL BLEEDING 2894
56 ABDOMINAL PAIN UPPER 2800
57 DEVICE USE ISSUE 2778
58 BREAST TENDERNESS 2772
59 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2712
60 POST PROCEDURAL HAEMORRHAGE 2560
61 MEDICAL DEVICE DISCOMFORT 2515
62 IUCD COMPLICATION 2445
63 OVARIAN CYST 2382
64 DEVICE KINK 2364
65 ABORTION SPONTANEOUS 2358
66 ARTHRALGIA 2275
67 FEELING ABNORMAL 2244
68 MEDICAL DEVICE COMPLICATION 2222
69 BREAST PAIN 2189
70 DYSPAREUNIA 2175
71 MENSTRUAL DISORDER 2164
72 INCORRECT DRUG ADMINISTRATION DURATION 2140
73 DIARRHOEA 2131
74 HYPOAESTHESIA 2089
75 MALAISE 2008
76 PREGNANCY AFTER POST COITAL CONTRACEPTION 1978
77 PRODUCT ADHESION ISSUE 1941
78 ADVERSE EVENT 1936
79 RASH 1795
80 PRODUCT USE IN UNAPPROVED INDICATION 1783
81 HAEMORRHAGE 1781
82 INSOMNIA 1766
83 ASTHENIA 1756
84 DYSPNOEA 1732
85 POST PROCEDURAL DISCOMFORT 1730
86 PARAESTHESIA 1716
87 PRURITUS 1690
88 URINARY TRACT INFECTION 1643
89 DEVICE PLACEMENT ISSUE 1633
90 HYPOMENORRHOEA 1633
91 WEIGHT DECREASED 1588
92 LOSS OF LIBIDO 1555
93 PYREXIA 1530
94 DISCOMFORT 1526
95 MEDICAL DEVICE PAIN 1516
96 CHEST PAIN 1508
97 ABDOMINAL DISCOMFORT 1487
98 IRRITABILITY 1462
99 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1457
100 DEPRESSED MOOD 1396
101 ECTOPIC PREGNANCY WITH CONTRACEPTIVE DEVICE 1393
102 MOOD ALTERED 1393
103 HOT FLUSH 1356
104 PALPITATIONS 1304
105 PRODUCT USE ISSUE 1290
106 INTENTIONAL PRODUCT MISUSE 1286
107 URTICARIA 1270
108 VISION BLURRED 1267
109 SUICIDAL IDEATION 1251
110 UNINTENTIONAL MEDICAL DEVICE REMOVAL 1250
111 POLYMENORRHOEA 1236
112 INFECTION 1200
113 MATERNAL EXPOSURE DURING PREGNANCY 1193
114 PENILE PAIN 1153
115 SYNCOPE 1104
116 HYPERTENSION 1095
117 UTERINE HAEMORRHAGE 1071
118 THROMBOSIS 1067
119 MATERNAL EXPOSURE BEFORE PREGNANCY 1061
120 INTERMENSTRUAL BLEEDING 1041
121 MENOMETRORRHAGIA 1034
122 UTERINE RUPTURE 1020
123 PANIC ATTACK 1011
124 UTERINE SPASM 1001
125 STRESS 984
126 UTERINE LEIOMYOMA 972
127 COITAL BLEEDING 969
128 HYPERHIDROSIS 969
129 LIBIDO DECREASED 965
130 DECREASED APPETITE 959
131 VERTIGO 951
132 VISUAL IMPAIRMENT 949
133 PRODUCT DOSE OMISSION ISSUE 941
134 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 931
135 CONSTIPATION 883
136 FUNGAL INFECTION 870
137 HYPERSENSITIVITY 848
138 EMOTIONAL DISORDER 847
139 EXPIRED DEVICE USED 837
140 GENERAL PHYSICAL HEALTH DETERIORATION 827
141 SCAR 807
142 ANAEMIA 801
143 LOSS OF CONSCIOUSNESS 796
144 ABORTION INDUCED 794
145 IUD MIGRATION 794
146 MYALGIA 786
147 SURGERY 781
148 PRESYNCOPE 770
149 CRYING 758
150 PRODUCT PRESCRIBING ISSUE 758
151 IMPLANT SITE ERYTHEMA 747
152 IMPLANT SITE PRURITUS 743
153 PROCEDURAL HAEMORRHAGE 741
154 CEREBROVASCULAR ACCIDENT 727
155 IDIOPATHIC INTRACRANIAL HYPERTENSION 722
156 PERIPHERAL SWELLING 716
157 DEVICE PHYSICAL PROPERTY ISSUE 706
158 IMPLANT SITE INFECTION 705
159 CONDITION AGGRAVATED 704
160 DEVICE MISUSE 687
161 TREMOR 684
162 SOMNOLENCE 665
163 PREGNANCY 663
164 NERVOUSNESS 662
165 PELVIC INFLAMMATORY DISEASE 662
166 ECTOPIC PREGNANCY 655
167 COUGH 647
168 OVERDOSE 644
169 ERYTHEMA 639
170 TINNITUS 638
171 BREAST CANCER 637
172 DEVICE FAILURE 636
173 NECK PAIN 634
174 DEVICE USE ERROR 632
175 IMPLANT SITE BRUISING 631
176 CONTUSION 623
177 FEAR 621
178 MEDICAL DEVICE SITE DISCOMFORT 619
179 ANHEDONIA 618
180 EXPOSURE DURING PREGNANCY 618
181 FALL 608
182 HORMONE LEVEL ABNORMAL 605
183 TACHYCARDIA 605
184 INFERTILITY FEMALE 603
185 MENTAL DISORDER 602
186 POLLAKIURIA 594
187 SLEEP DISORDER 590
188 IMPLANT SITE SWELLING 582
189 PNEUMONIA 582
190 VULVOVAGINAL DISCOMFORT 577
191 OFF LABEL USE OF DEVICE 576
192 SINUSITIS 573
193 BREAST CANCER FEMALE 561
194 VULVOVAGINAL PAIN 561
195 BLOOD PRESSURE INCREASED 560
196 NASOPHARYNGITIS 560
197 CHILLS 556
198 DRUG INTERACTION 546
199 AMNESIA 542
200 SWELLING 540
201 NIGHT SWEATS 537
202 GASTROOESOPHAGEAL REFLUX DISEASE 531
203 VAGINAL INFECTION 526
204 IMPLANT SITE SCAR 523
205 DYSURIA 521
206 OEDEMA PERIPHERAL 521
207 ADNEXA UTERI PAIN 514
208 SEIZURE 514
209 ANGER 513
210 ASTHMA 512
211 DISTURBANCE IN ATTENTION 512
212 MEMORY IMPAIRMENT 507
213 CERVICAL DYSPLASIA 501
214 DYSPEPSIA 500
215 LIMB DISCOMFORT 496
216 CHEST DISCOMFORT 491
217 OLIGOMENORRHOEA 490
218 DEVICE MALFUNCTION 489
219 FEELING HOT 488
220 MUSCULOSKELETAL PAIN 484
221 ENDOMETRIOSIS 475
222 HEART RATE INCREASED 475
223 HAEMORRHAGE IN PREGNANCY 467
224 DRUG DOSE OMISSION 464
225 RUPTURED ECTOPIC PREGNANCY 464
226 UTERINE CERVIX STENOSIS 458
227 GAIT DISTURBANCE 455
228 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 452
229 OROPHARYNGEAL PAIN 450
230 PRODUCT PHYSICAL ISSUE 448
231 DRUG HYPERSENSITIVITY 447
232 UTERINE PAIN 433
233 CYST 432
234 PREMENSTRUAL SYNDROME 428
235 MEDICATION ERROR 425
236 VAGINAL ODOUR 424
237 DEVICE DEFECTIVE 420
238 BRONCHITIS 419
239 MIGRATION OF IMPLANTED DRUG 409
240 BURNING SENSATION 405
241 VULVOVAGINAL PRURITUS 402
242 INTENTIONAL PRODUCT USE ISSUE 400
243 HYPOTENSION 397
244 EXPIRED PRODUCT ADMINISTERED 392
245 UNEVALUABLE EVENT 391
246 FLATULENCE 389
247 ADVERSE DRUG REACTION 383
248 IMPLANT SITE FIBROSIS 383
249 PAPILLOEDEMA 381
250 GENITAL PAIN 371
251 MUSCULAR WEAKNESS 371
252 ECZEMA 368
253 APPLICATION SITE RASH 366
254 AGGRESSION 364
255 COVID-19 359
256 CONVULSION 357
257 VULVOVAGINAL MYCOTIC INFECTION 357
258 PULMONARY INFARCTION 356
259 DRUG EXPOSURE DURING PREGNANCY 351
260 INJECTION SITE PAIN 349
261 GASTROINTESTINAL DISORDER 347
262 VULVOVAGINAL DRYNESS 344
263 INFLUENZA LIKE ILLNESS 342
264 IMPAIRED WORK ABILITY 341
265 BREAST SWELLING 338
266 SMEAR CERVIX ABNORMAL 338
267 HYPERCOAGULATION 336
268 ILLNESS 334
269 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 331
270 APPLICATION SITE PRURITUS 330
271 FLUID RETENTION 328
272 JOINT SWELLING 328
273 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 327
274 PRODUCT SUBSTITUTION ISSUE 327
275 INTERNAL INJURY 325
276 SWELLING FACE 325
277 DRY SKIN 324
278 INFLUENZA 324
279 MENINGIOMA 321
280 CONFUSIONAL STATE 320
281 ROAD TRAFFIC ACCIDENT 317
282 BACTERIAL VAGINOSIS 316
283 ABNORMAL UTERINE BLEEDING 313
284 CAESAREAN SECTION 313
285 DEHYDRATION 312
286 MUSCULOSKELETAL STIFFNESS 312
287 AFFECTIVE DISORDER 307
288 COAGULOPATHY 304
289 NIPPLE PAIN 303
290 IMPLANT SITE IRRITATION 298
291 HYPERTRICHOSIS 296
292 ABNORMAL WITHDRAWAL BLEEDING 293
293 CHOLELITHIASIS 293
294 ECTOPIC PREGNANCY WITH INTRAUTERINE DEVICE 292
295 DEVICE ADHESION ISSUE 291
296 FLUSHING 290
297 BREAST ENLARGEMENT 289
298 CONTRAINDICATED DEVICE USED 287
299 BREAST MASS 285
300 NEPHROLITHIASIS 285
301 BLINDNESS 284
302 UPPER RESPIRATORY TRACT INFECTION 284
303 VAGINITIS BACTERIAL 282
304 THERAPEUTIC RESPONSE UNEXPECTED 281
305 PREGNANCY ON CONTRACEPTIVE 280
306 HYPOTHYROIDISM 279
307 FOETAL EXPOSURE DURING PREGNANCY 277
308 APPLICATION SITE ERYTHEMA 272
309 OVARIAN CYST RUPTURED 272
310 CYSTITIS 269
311 DIPLOPIA 269
312 RASH PRURITIC 269
313 SKIN DISCOLOURATION 268
314 IMPLANT SITE RASH 267
315 INTRACRANIAL PRESSURE INCREASED 263
316 INCREASED APPETITE 261
317 SUPPRESSED LACTATION 261
318 MEDICAL DEVICE MONITORING ERROR 259
319 NEURALGIA 258
320 PSORIASIS 258
321 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 256
322 CELLULITIS 255
323 IMPLANT SITE HAEMORRHAGE 254
324 PRODUCT STORAGE ERROR 254
325 BENIGN INTRACRANIAL HYPERTENSION 251
326 BREAST DISCHARGE 250
327 DERMATITIS ATOPIC 250
328 GENERAL ANAESTHESIA 247
329 INCORRECT DOSE ADMINISTERED 247
330 HAEMOGLOBIN DECREASED 245
331 LYMPHADENOPATHY 243
332 AFFECT LABILITY 242
333 DRUG ADMINISTRATION ERROR 242
334 INFLAMMATION 240
335 HIRSUTISM 239
336 RASH GENERALISED 237
337 SKIN DISORDER 236
338 APPLICATION SITE IRRITATION 235
339 PELVIC DISCOMFORT 233
340 BALANCE DISORDER 230
341 SUICIDE ATTEMPT 229
342 NASAL CONGESTION 227
343 PLEURAL EFFUSION 225
344 LIMB INJURY 222
345 TRANSIENT ISCHAEMIC ATTACK 221
346 PREMATURE BABY 219
347 POLYCYSTIC OVARIES 217
348 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 216
349 BLOOD URINE PRESENT 215
350 INTRA-UTERINE CONTRACEPTIVE DEVICE REMOVAL 215
351 LETHARGY 215
352 MOBILITY DECREASED 215
353 SEPSIS 215
354 HUNGER 214
355 NEEDLE ISSUE 213
356 RASH ERYTHEMATOUS 212
357 DIFFUSE ALOPECIA 211
358 CHOLECYSTECTOMY 210
359 EPILEPSY 209
360 CHLAMYDIAL INFECTION 208
361 EPISTAXIS 208
362 RASH MACULAR 208
363 VULVOVAGINAL BURNING SENSATION 208
364 HYSTERECTOMY 207
365 PHOTOPHOBIA 207
366 WITHDRAWAL BLEED 206
367 ACTIVITIES OF DAILY LIVING IMPAIRED 204
368 BLOOD PRESSURE DECREASED 204
369 DEVICE EMBOLISATION 203
370 INJECTION SITE ERYTHEMA 203
371 PROCEDURAL COMPLICATION 203
372 DYSGEUSIA 202
373 SPEECH DISORDER 201
374 MENSTRUATION NORMAL 200
375 SKIN EXFOLIATION 200
376 ABNORMAL WEIGHT GAIN 199
377 ACNE CYSTIC 198
378 DYSPHAGIA 198
379 DRY EYE 196
380 IRON DEFICIENCY ANAEMIA 196
381 DRY MOUTH 195
382 GALACTORRHOEA 195
383 TREATMENT NONCOMPLIANCE 194
384 INFERTILITY 193
385 ABORTION 192
386 OBESITY 192
387 RHEUMATOID ARTHRITIS 192
388 IMPLANT SITE HYPOAESTHESIA 191
389 RESTLESSNESS 191
390 EYE PAIN 190
391 IRRITABLE BOWEL SYNDROME 190
392 MATERNAL EXPOSURE DURING BREAST FEEDING 188
393 PRODUCT DOSE OMISSION 188
394 ATELECTASIS 187
395 OEDEMA 187
396 THROMBOPHLEBITIS SUPERFICIAL 187
397 MYOCARDIAL INFARCTION 186
398 SKIN BURNING SENSATION 184
399 INCORRECT PRODUCT STORAGE 182
400 COGNITIVE DISORDER 181
401 GALLBLADDER DISORDER 181
402 POOR QUALITY DEVICE USED 181
403 IMPLANT SITE REACTION 180
404 STAPHYLOCOCCAL INFECTION 180
405 ARRHYTHMIA 179
406 UTERINE POLYP 179
407 DYSFUNCTIONAL UTERINE BLEEDING 178
408 HYPOKALAEMIA 178
409 EXPOSURE DURING BREAST FEEDING 177
410 FLANK PAIN 176
411 SLEEP APNOEA SYNDROME 176
412 BIPOLAR DISORDER 175
413 AGITATION 174
414 APATHY 174
415 BACTERIAL INFECTION 173
416 VISUAL ACUITY REDUCED 172
417 HAIR GROWTH ABNORMAL 169
418 IMPAIRED HEALING 169
419 BREAST CYST 168
420 BREAST DISCOMFORT 168
421 FIBROMYALGIA 168
422 POOR QUALITY SLEEP 168
423 INTRA-ABDOMINAL HAEMORRHAGE 167
424 MIGRAINE WITH AURA 167
425 ARTHRITIS 166
426 VIRAL INFECTION 165
427 URINARY INCONTINENCE 164
428 WEIGHT LOSS POOR 163
429 BLOOD GLUCOSE INCREASED 162
430 EMBOLISM VENOUS 161
431 HAEMATOCHEZIA 160
432 PAPILLOMA VIRAL INFECTION 160
433 SKIN IRRITATION 160
434 BLISTER 159
435 DEPRESSION SUICIDAL 159
436 TENDONITIS 159
437 VISUAL FIELD DEFECT 159
438 APHASIA 158
439 FEELING COLD 158
440 IMPLANT SITE CELLULITIS 158
441 MENOPAUSAL SYMPTOMS 158
442 ALANINE AMINOTRANSFERASE INCREASED 157
443 DRUG INTOLERANCE 157
444 FOOD CRAVING 157
445 CEREBRAL INFARCTION 156
446 INTRACRANIAL VENOUS SINUS THROMBOSIS 156
447 MUSCLE TWITCHING 156
448 ANAPHYLACTIC REACTION 155
449 APPLICATION SITE PAIN 154
450 MAJOR DEPRESSION 154
451 ABNORMAL BEHAVIOUR 153
452 HYPERSOMNIA 153
453 PALLOR 153
454 PRODUCT PRESCRIBING ERROR 153
455 CROHN^S DISEASE 152
456 MICTURITION URGENCY 152
457 RHINORRHOEA 152
458 THROAT TIGHTNESS 152
459 WHITE BLOOD CELL COUNT INCREASED 152
460 KIDNEY INFECTION 150
461 LIP SWELLING 150
462 PRURITUS GENERALISED 150
463 EYE SWELLING 149
464 MULTIPLE SCLEROSIS 149
465 MUSCULOSKELETAL CHEST PAIN 149
466 DRUG PRESCRIBING ERROR 148
467 BRAIN FOG 147
468 SYSTEMIC LUPUS ERYTHEMATOSUS 147
469 MIDDLE INSOMNIA 146
470 MUSCLE TIGHTNESS 146
471 VARICOSE VEIN 146
472 CERVIX DISORDER 145
473 INCORRECT ROUTE OF DRUG ADMINISTRATION 145
474 PHARYNGITIS STREPTOCOCCAL 145
475 PRODUCT SHAPE ISSUE 145
476 BLOOD CHOLESTEROL INCREASED 144
477 DIFFICULTY REMOVING DRUG IMPLANT 144
478 IMPLANT SITE DISCHARGE 144
479 PULMONARY HYPERTENSION 144
480 QUALITY OF LIFE DECREASED 144
481 CONTRAINDICATED PRODUCT ADMINISTERED 143
482 FORMICATION 143
483 TRICUSPID VALVE INCOMPETENCE 143
484 LEUKOCYTOSIS 142
485 VULVOVAGINAL SWELLING 142
486 PATIENT-DEVICE INCOMPATIBILITY 141
487 HEAD DISCOMFORT 140
488 PHARYNGITIS 140
489 THYROID DISORDER 140
490 UTERINE DISORDER 140
491 VAGINAL CONTRACEPTIVE DEVICE EXPELLED 140
492 HEPATIC ENZYME INCREASED 139
493 APPENDICITIS 138
494 HEART RATE IRREGULAR 138
495 PSYCHOTIC DISORDER 138
496 THROAT IRRITATION 138
497 COLD SWEAT 137
498 DIABETES MELLITUS 137
499 EAR INFECTION 137
500 VENA CAVA FILTER INSERTION 137
501 BODY TEMPERATURE INCREASED 136
502 CARDIAC DISORDER 136
503 CEREBRAL VENOUS THROMBOSIS 136
504 DEATH 136
505 ENDOMETRITIS 136
506 HOSPITALISATION 136
507 IMPLANT SITE INJURY 136
508 JOINT INJURY 135
509 UTERINE INFECTION 135
510 ABDOMINAL TENDERNESS 134
511 POST-TRAUMATIC STRESS DISORDER 134
512 RECTAL HAEMORRHAGE 134
513 UTERINE ENLARGEMENT 134
514 PREMATURE DELIVERY 133
515 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 133
516 PROCEDURAL NAUSEA 133
517 COLITIS ULCERATIVE 132
518 HEPATIC STEATOSIS 132
519 PRE-EXISTING CONDITION IMPROVED 132
520 SALPINGECTOMY 132
521 BONE PAIN 131
522 HAEMORRHOIDS 131
523 PSYCHOLOGICAL TRAUMA 131
524 ANTEPARTUM HAEMORRHAGE 130
525 INJECTION SITE PRURITUS 130
526 TENDERNESS 130
527 INJECTION SITE SWELLING 129
528 IMPLANT SITE INFLAMMATION 128
529 INJECTION SITE REACTION 128
530 GASTRITIS 127
531 PRODUCT ADMINISTRATION INTERRUPTED 127
532 ABORTION MISSED 126
533 MOVEMENT DISORDER 126
534 DERMATITIS CONTACT 125
535 HAEMOPTYSIS 125
536 IMPLANT SITE PARAESTHESIA 125
537 MUSCLE STRAIN 125
538 UTERINE DILATION AND CURETTAGE 125
539 DERMATITIS 124
540 ANGIOEDEMA 123
541 ARTHROPATHY 123
542 DISEASE RECURRENCE 123
543 LIGAMENT SPRAIN 123
544 PANCREATITIS 122
545 PROCEDURAL DIZZINESS 122
546 GASTRIC DISORDER 121
547 HAEMATURIA 121
548 IMPLANT SITE MASS 121
549 DYSARTHRIA 120
550 HAEMORRHAGIC OVARIAN CYST 120
551 NEUROPATHY PERIPHERAL 120
552 THROMBOPHLEBITIS 120
553 ASPARTATE AMINOTRANSFERASE INCREASED 119
554 IMPLANT SITE DISCOLOURATION 119
555 NIGHTMARE 119
556 ADVERSE REACTION 118
557 INJURY ASSOCIATED WITH DEVICE 118
558 ACCIDENTAL EXPOSURE TO PRODUCT 117
559 NERVE INJURY 117
560 CHROMATURIA 116
561 DEVICE RELATED INFECTION 116
562 PULMONARY MASS 116
563 VAGINAL MYCOSIS 116
564 HYPERLIPIDAEMIA 115
565 MUSCULOSKELETAL DISCOMFORT 115
566 APPENDICECTOMY 114
567 DYSPNOEA EXERTIONAL 114
568 INTERVERTEBRAL DISC PROTRUSION 114
569 PHLEBITIS 114
570 ABASIA 113
571 ISCHAEMIC STROKE 113
572 SINUS TACHYCARDIA 113
573 CERVICITIS 112
574 EYE IRRITATION 112
575 HAEMATOMA 112
576 LIVER FUNCTION TEST ABNORMAL 112
577 SWOLLEN TONGUE 112
578 UTERINE SCAR 111
579 CARDIAC ARREST 110
580 EAR PAIN 110
581 ANGINA PECTORIS 109
582 INJECTION SITE BRUISING 109
583 PERITONEAL HAEMORRHAGE 109
584 PROCEDURAL VOMITING 109
585 VITAMIN D DEFICIENCY 109
586 DISORIENTATION 108
587 DYSSTASIA 108
588 HEAD INJURY 108
589 PAIN IN JAW 108
590 WITHDRAWAL SYNDROME 108
591 BLOOD POTASSIUM DECREASED 107
592 GENITAL DISCHARGE 107
593 HEPATIC ADENOMA 107
594 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 107
595 PARANOIA 107
596 MULTIPLE SCLEROSIS RELAPSE 106
597 PANIC REACTION 106
598 PELVIC INFECTION 106
599 POST PROCEDURAL COMPLICATION 106
600 SEXUAL DYSFUNCTION 106
601 EATING DISORDER 105
602 IMPLANT SITE VESICLES 105
603 POSTMENOPAUSAL HAEMORRHAGE 105
604 SCIATICA 105
605 VULVOVAGINAL CANDIDIASIS 105
606 RETCHING 104
607 SEASONAL ALLERGY 104
608 SEBORRHOEA 104
609 HALLUCINATION 103
610 PLEURISY 103
611 THERAPY CESSATION 103
612 THROMBOCYTOPENIA 102
613 UTERINE CERVICAL PAIN 102
614 ADENOMYOSIS 101
615 MITRAL VALVE INCOMPETENCE 101
616 WOUND 101
617 CERVIX CARCINOMA 100
618 CHOLECYSTITIS CHRONIC 100
619 INCORRECT DOSAGE ADMINISTERED 100
620 LOCAL SWELLING 100
621 NERVOUS SYSTEM DISORDER 100
622 PAIN OF SKIN 100
623 HEART RATE DECREASED 99
624 PREGNANCY TEST POSITIVE 99
625 PYELONEPHRITIS 99
626 RASH PAPULAR 99
627 FEELING JITTERY 98
628 C-REACTIVE PROTEIN INCREASED 97
629 IMPLANT SITE ABSCESS 97
630 INTENTIONAL DOSE OMISSION 97
631 PRODUCT ADMINISTRATION ERROR 97
632 WEIGHT FLUCTUATION 97
633 WRONG TECHNIQUE IN DRUG USAGE PROCESS 97
634 ANXIETY DISORDER 96
635 LOOP ELECTROSURGICAL EXCISION PROCEDURE 96
636 PREGNANCY ON ORAL CONTRACEPTIVE 96
637 SENSORY DISTURBANCE 96
638 FREQUENT BOWEL MOVEMENTS 95
639 PAROSMIA 95
640 THERAPEUTIC RESPONSE DECREASED 95
641 VENOUS THROMBOSIS 95
642 CARPAL TUNNEL SYNDROME 94
643 HEREDITARY ANGIOEDEMA 94
644 INFUSION RELATED REACTION 94
645 RHINITIS ALLERGIC 94
646 SALPINGITIS 94
647 THIRST 94
648 GASTROENTERITIS VIRAL 93
649 ACUTE KIDNEY INJURY 92
650 BLOOD IRON DECREASED 92
651 GROIN PAIN 92
652 MASS 92
653 AUTOIMMUNE DISORDER 91
654 DYSPHONIA 91
655 THINKING ABNORMAL 91
656 ENDOMETRIAL CANCER 90
657 ENDOMETRIAL HYPERPLASIA 90
658 FEMALE STERILISATION 90
659 IMPLANT SITE WARMTH 90
660 INVASIVE DUCTAL BREAST CARCINOMA 90
661 PRODUCT DOSE OMISSION IN ERROR 90
662 SECRETION DISCHARGE 90
663 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 90
664 ACCIDENTAL UNDERDOSE 89
665 BLOOD LOSS ANAEMIA 89
666 DERMATITIS ALLERGIC 89
667 PELVIC ADHESIONS 89
668 PREMATURE LABOUR 89
669 RESTLESS LEGS SYNDROME 89
670 ABSCESS 88
671 AUTOIMMUNE THYROIDITIS 88
672 HEMIPARESIS 88
673 PLATELET COUNT DECREASED 88
674 DEVICE INTOLERANCE 87
675 EYE PRURITUS 87
676 GASTROINTESTINAL INJURY 87
677 GENERALISED TONIC-CLONIC SEIZURE 87
678 HAEMATEMESIS 87
679 HERPES ZOSTER 87
680 INTERNATIONAL NORMALISED RATIO INCREASED 87
681 PRODUCT CONTAMINATION 87
682 PSORIATIC ARTHROPATHY 87
683 BREAST FEEDING 86
684 INTENTIONAL DEVICE MISUSE 86
685 MENTAL IMPAIRMENT 86
686 PERITONITIS 86
687 PROCEDURAL ANXIETY 86
688 SINUS DISORDER 86
689 TEARFULNESS 86
690 OSTEOARTHRITIS 85
691 PELVIC FLUID COLLECTION 85
692 RESPIRATORY DISORDER 85
693 RESPIRATORY FAILURE 85
694 CHLOASMA 84
695 EXPIRED DRUG ADMINISTERED 84
696 HAEMORRHAGIC ANAEMIA 84
697 HYPERTHYROIDISM 84
698 LUNG DISORDER 84
699 OCULAR DISCOMFORT 84
700 BLINDNESS TRANSIENT 83
701 BLOOD BILIRUBIN INCREASED 83
702 IMPAIRED QUALITY OF LIFE 83
703 IMPLANT SITE URTICARIA 83
704 SENSATION OF FOREIGN BODY 83
705 DYSKINESIA 82
706 MEDICAL DEVICE SITE PAIN 82
707 PERIPHERAL COLDNESS 82
708 PERSONALITY CHANGE 82
709 SUPERIOR SAGITTAL SINUS THROMBOSIS 82
710 ABNORMAL DREAMS 81
711 GASTROENTERITIS 81
712 LIVER DISORDER 81
713 OCULAR HYPERAEMIA 81
714 THERAPY INTERRUPTED 81
715 APPLICATION SITE DISCOMFORT 80
716 CEREBRAL HAEMORRHAGE 80
717 CIRCULATORY COLLAPSE 80
718 NEOPLASM MALIGNANT 80
719 PRODUCT AVAILABILITY ISSUE 80
720 ABDOMINAL ADHESIONS 79
721 CARDIOVASCULAR DISORDER 79
722 DEVICE INEFFECTIVE 79
723 HYPOAESTHESIA ORAL 79
724 PRODUCTIVE COUGH 79
725 RENAL FAILURE 79
726 TREATMENT FAILURE 79
727 FOETAL DEATH 78
728 GRAND MAL CONVULSION 78
729 IMPLANT SITE INDURATION 78
730 JAUNDICE 78
731 MATERNAL DRUGS AFFECTING FOETUS 78
732 MENOPAUSE 78
733 URINARY RETENTION 78
734 UTERINE INJURY 78
735 ACUTE MYOCARDIAL INFARCTION 77
736 ANAPHYLACTIC SHOCK 77
737 COMPLICATION OF PREGNANCY 77
738 RETAINED PRODUCTS OF CONCEPTION 77
739 SEPTIC SHOCK 77
740 TENSION HEADACHE 77
741 TYPE 2 DIABETES MELLITUS 77
742 VAGINAL DISORDER 77
743 ASCITES 76
744 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 76
745 EYE DISORDER 76
746 FEEDING DISORDER 76
747 FEELING OF BODY TEMPERATURE CHANGE 76
748 FURUNCLE 76
749 IRON DEFICIENCY 76
750 NERVE COMPRESSION 76
751 OVERWEIGHT 76
752 PREGNANCY TEST FALSE POSITIVE 76
753 SKIN LESION 76
754 URINE ODOUR ABNORMAL 76
755 ANTIPHOSPHOLIPID ANTIBODIES POSITIVE 75
756 COLITIS 75
757 FEAR OF DISEASE 75
758 HAEMOPERITONEUM 75
759 PANIC DISORDER 75
760 PREMATURE MENOPAUSE 75
761 RESPIRATORY TRACT INFECTION 75
762 TRANSVERSE SINUS THROMBOSIS 75
763 FACE OEDEMA 74
764 ILL-DEFINED DISORDER 74
765 INTERNAL HAEMORRHAGE 74
766 PRE-ECLAMPSIA 74
767 PRODUCT PACKAGING QUANTITY ISSUE 74
768 SKIN ODOUR ABNORMAL 74
769 THERAPEUTIC PRODUCT EFFECT DECREASED 74
770 UTERINE CYST 74
771 CERVICAL POLYP 73
772 DRUG EFFECT DECREASED 73
773 ECONOMIC PROBLEM 73
774 ENDOMETRIAL THICKENING 73
775 ERUCTATION 73
776 GASTROINTESTINAL PAIN 73
777 IMPLANT SITE HYPERSENSITIVITY 73
778 INITIAL INSOMNIA 73
779 OVULATION PAIN 73
780 PROGESTERONE RECEPTOR ASSAY POSITIVE 73
781 PULMONARY THROMBOSIS 73
782 TUBO-OVARIAN ABSCESS 73
783 FRUSTRATION TOLERANCE DECREASED 72
784 POOR QUALITY DRUG ADMINISTERED 72
785 TONSILLECTOMY 72
786 TOOTHACHE 72
787 APPLICATION SITE REACTION 71
788 DEVICE IMPLANTATION ERROR 71
789 GAIT INABILITY 71
790 GESTATIONAL DIABETES 71
791 INCREASED TENDENCY TO BRUISE 71
792 NEGATIVE THOUGHTS 71
793 ORAL HERPES 71
794 PENIS INJURY 71
795 SENSORY LOSS 71
796 THERAPEUTIC RESPONSE SHORTENED 71
797 BLINDNESS UNILATERAL 70
798 CANDIDA INFECTION 70
799 DRUG-INDUCED LIVER INJURY 70
800 FIBRIN D DIMER INCREASED 70
801 HERPES SIMPLEX 70
802 HIDRADENITIS 70
803 NORMAL NEWBORN 70
804 RASH MACULO-PAPULAR 70
805 BRADYCARDIA 69
806 GAMMA-GLUTAMYLTRANSFERASE INCREASED 69
807 HYPERVENTILATION 69
808 LACRIMATION INCREASED 69
809 PELVIC VENOUS THROMBOSIS 69
810 PLEURITIC PAIN 69
811 WHEEZING 69
812 DEPRESSIVE SYMPTOM 68
813 EXTRASYSTOLES 68
814 HEPATIC CYST 68
815 MULTIPLE INJURIES 68
816 PHARMACEUTICAL PRODUCT COMPLAINT 68
817 TOOTH DISORDER 68
818 CARDIAC MURMUR 67
819 FOOD ALLERGY 67
820 CEREBRAL THROMBOSIS 66
821 DEVICE COMPONENT ISSUE 66
822 DRUG WITHDRAWAL SYNDROME 66
823 FIBROCYSTIC BREAST DISEASE 66
824 HAEMANGIOMA OF LIVER 66
825 HAIR TEXTURE ABNORMAL 66
826 HYDROMETRA 66
827 VITREOUS FLOATERS 66
828 DEAFNESS 65
829 DECREASED INTEREST 65
830 HUMAN PAPILLOMA VIRUS TEST POSITIVE 65
831 HYPOGLYCAEMIA 65
832 INTENTIONAL SELF-INJURY 65
833 INTERNATIONAL NORMALISED RATIO DECREASED 65
834 JOINT STIFFNESS 65
835 NIPPLE DISORDER 65
836 PHOTOSENSITIVITY REACTION 65
837 BACK DISORDER 64
838 EAR DISCOMFORT 64
839 IMPAIRED DRIVING ABILITY 64
840 RENAL DISORDER 64
841 THROMBECTOMY 64
842 WHITE BLOOD CELL COUNT DECREASED 64
843 COELIAC DISEASE 63
844 DISABILITY 63
845 FACIAL PARALYSIS 63
846 HAEMATOCRIT DECREASED 63
847 MENSTRUAL CLOTS 63
848 PROCTALGIA 63
849 PRODUCT COLOUR ISSUE 63
850 PROGESTERONE DECREASED 63
851 SUBARACHNOID HAEMORRHAGE 63
852 SUPRAVENTRICULAR TACHYCARDIA 63
853 VOMITING IN PREGNANCY 63
854 DEFORMITY 62
855 INTENTIONAL DEVICE USE ISSUE 62
856 LACERATION 62
857 MEDICAL DEVICE REMOVAL 62
858 OESTROGEN RECEPTOR ASSAY POSITIVE 62
859 SEXUALLY TRANSMITTED DISEASE 62
860 SKIN INFECTION 62
861 STREPTOCOCCAL INFECTION 62
862 WISDOM TEETH REMOVAL 62
863 CHOLECYSTITIS 61
864 INSURANCE ISSUE 61
865 VENTRICULAR EXTRASYSTOLES 61
866 ATTENTION DEFICIT/HYPERACTIVITY DISORDER 60
867 BREAST DISORDER 60
868 FOCAL NODULAR HYPERPLASIA 60
869 FOOT FRACTURE 60
870 HYPOACUSIS 60
871 HYPONATRAEMIA 60
872 INFUSION SITE PAIN 60
873 PARAESTHESIA ORAL 60
874 SKIN FISSURES 60
875 THERAPY NON-RESPONDER 60
876 THYROID NEOPLASM 60
877 VITAMIN B12 DEFICIENCY 60
878 DEVICE ALLERGY 59
879 GASTRIC BYPASS 59
880 GOITRE 59
881 GONORRHOEA 59
882 INTENTIONAL OVERDOSE 59
883 LUNG INFILTRATION 59
884 PIGMENTATION DISORDER 59
885 PREMATURE RUPTURE OF MEMBRANES 59
886 RENAL PAIN 59
887 SELF-INJURIOUS IDEATION 59
888 SNEEZING 59
889 ABORTION OF ECTOPIC PREGNANCY 58
890 ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC 58
891 APPLICATION SITE BURN 58
892 ATRIAL FIBRILLATION 58
893 BLOOD PRESSURE FLUCTUATION 58
894 CARDIOMEGALY 58
895 ENDOMETRIAL DISORDER 58
896 HYPERGLYCAEMIA 58
897 MENTAL STATUS CHANGES 58
898 PRODUCT PACKAGING ISSUE 58
899 PRODUCT SOLUBILITY ABNORMAL 58
900 SKIN HYPERPIGMENTATION 58
901 SYNCOPE VASOVAGAL 58
902 UTERINE INFLAMMATION 58
903 ACTINOMYCOSIS 57
904 ANKLE FRACTURE 57
905 BEDRIDDEN 57
906 CONJUNCTIVITIS 57
907 ERYTHEMA NODOSUM 57
908 HIGH RISK PREGNANCY 57
909 IMPLANT SITE HAEMATOMA 57
910 INJECTION SITE RASH 57
911 LIVER FUNCTION TEST INCREASED 57
912 OPTIC NEURITIS 57
913 PANCREATITIS ACUTE 57
914 PERITONEAL ADHESIONS 57
915 UNDERDOSE 57
916 APPETITE DISORDER 56
917 BLIGHTED OVUM 56
918 CONCUSSION 56
919 EMBOLISM 56
920 LACTATION DISORDER 56
921 MANIA 56
922 PHARYNGEAL OEDEMA 56
923 PORTAL VEIN THROMBOSIS 56
924 PULMONARY OEDEMA 56
925 SPINAL PAIN 56
926 UTERINE ADHESIONS 56
927 APPLICATION SITE VESICLES 55
928 ARTHROPOD BITE 55
929 FIBROADENOMA OF BREAST 55
930 HYPERAESTHESIA 55
931 IMPAIRED GASTRIC EMPTYING 55
932 INJECTION SITE HAEMORRHAGE 55
933 PREMENSTRUAL DYSPHORIC DISORDER 55
934 PSYCHIATRIC SYMPTOM 55
935 TEMPERATURE INTOLERANCE 55
936 ABNORMAL MENSTRUAL CLOTS 54
937 ACTINOMYCES TEST POSITIVE 54
938 BLOOD ALKALINE PHOSPHATASE INCREASED 54
939 DRUG DEPENDENCE 54
940 ENCAPSULATION REACTION 54
941 HEMIPLEGIA 54
942 KELOID SCAR 54
943 KNEE OPERATION 54
944 OXYGEN SATURATION DECREASED 54
945 PLANTAR FASCIITIS 54
946 PURULENT DISCHARGE 54
947 RAYNAUD^S PHENOMENON 54
948 ANTIPHOSPHOLIPID SYNDROME 53
949 ATRIAL SEPTAL DEFECT 53
950 EXTRA DOSE ADMINISTERED 53
951 FEELING OF DESPAIR 53
952 LIVE BIRTH 53
953 MAMMOPLASTY 53
954 OOPHORECTOMY 53
955 OVARIAN CANCER 53
956 OVARIAN DISORDER 53
957 POST THROMBOTIC SYNDROME 53
958 RENAL CYST 53
959 ROSACEA 53
960 SUBCLAVIAN VEIN THROMBOSIS 53
961 VULVOVAGINAL INJURY 53
962 AGEUSIA 52
963 DIZZINESS POSTURAL 52
964 FOREIGN BODY IN REPRODUCTIVE TRACT 52
965 GENITAL DISCOMFORT 52
966 PHARYNGEAL SWELLING 52
967 POST ABORTION HAEMORRHAGE 52
968 BLOOD GLUCOSE DECREASED 51
969 FALLOPIAN TUBE PERFORATION 51
970 HYPERPHAGIA 51
971 IMMUNODEFICIENCY 51
972 INJECTION SITE URTICARIA 51
973 PRODUCT COMPLAINT 51
974 SKIN REACTION 51
975 TRANSFUSION 51
976 ANTINUCLEAR ANTIBODY POSITIVE 50
977 COSTOCHONDRITIS 50
978 DEPRESSED LEVEL OF CONSCIOUSNESS 50
979 DRUG EXPOSURE BEFORE PREGNANCY 50
980 FOETAL GROWTH RESTRICTION 50
981 HIATUS HERNIA 50
982 POST PROCEDURAL INFECTION 50
983 POSTPARTUM HAEMORRHAGE 50
984 SCRATCH 50
985 SCREAMING 50
986 BLOOD DISORDER 49
987 CARDIO-RESPIRATORY ARREST 49
988 GENERALISED ANXIETY DISORDER 49
989 GENITAL HERPES 49
990 GINGIVAL BLEEDING 49
991 MUSCULOSKELETAL DISORDER 49
992 PHOTOPSIA 49
993 SHOCK 49
994 TRICHORRHEXIS 49
995 UTERINE CANCER 49
996 ALOPECIA AREATA 48
997 ANKYLOSING SPONDYLITIS 48
998 APPLICATION SITE SWELLING 48
999 BLADDER DISORDER 48